FOXO transcription factors at the interface of metabolism and cancer

Int J Cancer. 2017 Dec 15;141(12):2379-2391. doi: 10.1002/ijc.30840. Epub 2017 Jul 10.

Abstract

Diabetes refers to a group of metabolic diseases characterized by impaired insulin signalling and high blood glucose. A growing body of epidemiological evidence links diabetes to several types of cancer but the underlying molecular mechanisms are poorly understood. The signalling cascade connecting insulin and FOXO proteins provides a compelling example for a conserved pathway at the interface between insulin signalling and cancer. FOXOs are transcription factors that orchestrate programs of gene expression known to control a variety of processes in response to cellular stress. Genes regulated by this family of proteins are involved in the regulation of cellular energy production, oxidative stress resistance and cell viability and proliferation. Accordingly, FOXO factors have been shown to play an important role in the suppression of tumour growth and in the regulation of metabolic homeostasis. There is emerging evidence that deregulation of FOXO factors might account for the association between insulin resistance-related metabolic disorders and cancer.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Proliferation
  • Cell Survival
  • Diabetes Mellitus / genetics
  • Diabetes Mellitus / metabolism*
  • Forkhead Transcription Factors / metabolism*
  • Gene Expression Regulation, Neoplastic
  • Gene Regulatory Networks
  • Humans
  • Insulin / metabolism*
  • Neoplasms / complications
  • Neoplasms / metabolism*
  • Oxidative Stress
  • Signal Transduction

Substances

  • Forkhead Transcription Factors
  • Insulin